ERVIN GRAVES STRATEGY GROUP, LLC

Lobbying for AMERICAN MEDICINES COMPANY · Manufacturer of Generic Medication

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $30,000.00 income · posted Jul 16, 2025

Lobbying activity 1

Health Issues

Appropriations/Funding and Support for strengthening the domestic supply chain for generic medication manufacturing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.